Emisssion – ja tak – eller ?:

By On 12. September 2012 · 3 Comments · In BioPorto

About Stengaard

BioPorto investor from way back when... I've invested in BioPorto ever since they made their debut on the danish stock exchange, it been a looooong journey with many obstacles. But well worth it all if Bioporto maintains their patent after the proceedings in 2014, and enters into agreements with Global Distributors in 2012 and 2013 If not, then it'll take another xx.years 🙂

Related posts:

  1. 1st Class versus Second Rate… User Ann (again)   – I’m having a hard time...
  2. Thea Olesen in Medwatch RSVP (répondez, s’il vous plaît) in Medwatch – Thea Olesen....
  3. The recent development in Triage/Trauma NGAL-patent The USPTO’s Christine Foster ist still not happy with the...
  4. BioPorto vs Phadia … BioPorto won 2-0 Today the judges of Sø & Handelsretten gave their verdict...
  5. NGAL BioPorto and Phadia in Medwatch.dk NGAL – For the benefit of our esteemed readers from...
 

3 Responses to Emisssion – ja tak – eller ?:

  1. stengaard says:
    12. September 2012 at 16:21

    frit efter Groucho Marx; med den slags ærekrænkede polls må jeg overveje at opsige mit abbonement

    Reply
    • Medicoinvestor says:
      12. September 2012 at 16:42

      Du har ikke noget abbonement, så der er ikke noget af opsige… så du bliver bare her. 🙂

      Reply
  2. Medicoinvestor says:
    12. September 2012 at 13:18

    [polldaddy 6529069 http://answers.polldaddy.com/poll/6529069/ polldaddy]

    😉

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *

Set your Twitter account name in your settings to use the TwitterBar Section.